PHR
Phreesia
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 4
Sell signal 0
consensus rating "Strong Buy"
ample liquidity
High Gross Profit Margin
EPS Beats Expectation
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About PHR
Phreesia, Inc.
A healthcare technology company that provides patient intake and payment solutions to medical groups and health systems
Healthcare Technology
Invalid Date
07/18/2019
New York Stock Exchange
2082
01-31
Common stock
1521 Concord Pike
, Suite 301 PMB 221
, Wilmington
, DE 19803
--
Phreesia, Inc., was incorporated in 2005 under the laws of the State of Delaware. The company is a leading provider of comprehensive solutions that transform the healthcare experience, clinical care by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, increase profitability and improve. Through the SaaS-based Phreesia platform, the company provides healthcare provider organizations with a powerful set of solutions to manage the patient admission process, as well as an integrated payment solution for the safe processing of patient payments. The company's platform also provides life science companies with an engagement channel for targeted and direct communication with patients.
Company Financials
EPS
PHR has released its 2025 Q4 earnings. EPS was reported at -0.11, versus the expected 0.11, missing expectations. The chart below visualizes how PHR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PHR has released its 2025 Q4 earnings report, with revenue of 109.68M, reflecting a YoY change of 15.45%, and net profit of -6.39M, showing a YoY change of 79.15%. The Sankey diagram below clearly presents PHR’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
